Shandell Jason B.

President And General Counsel | President

1 company

Shandell Jason B. is a President And General Counsel at Amphastar Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.

Estimated insider holdings value: $3.5M based on current market prices.

Holdings by Company

AMPHMar 17, 2020

Current Shares179.3K

Value$3.54M

Net Activity-439,972

Bought: 0Sold: 440.0K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Jan 23, 2019	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	15,497	$22.39	$347,019.46	-4.4%
Dec 3, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sale+OE	16,630	$22.44	$373,177.20	-8.3%
Nov 14, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	16,015	$20.41	$326,854.66	-4.2%
Nov 9, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sale+OE	52,296	$20.77	$1,086,420.05	-11.6%
Jul 11, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	14,399	$16.77	$241,422.27	-6.7%
Mar 20, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	20,000	$19.43	$388,638.00	-4.2%
Mar 14, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sale+OE	700	$20.45	$14,315.00	-0.2%
Jan 26, 2018	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	18,627	$19.42	$361,747.11	-4.0%
May 31, 2017	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sell	11,482	$16.92	$194,300.39	-2.3%
Nov 28, 2016	AMPH Amphastar Pharmaceuticals, Inc.	President And General Counsel	Sale+OE	26,335	$20.48	$539,258.16	-6.1%